Last reviewed: June 10, 2026

Last updated: June 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic pens are designed as multi-dose delivery devices that let patients administer their own weekly semaglutide injections at home. Each pen contains enough medication for up to 4 weeks of treatment, depending on the patient's dose level and the pen size purchased. Understanding how Ozempic pens work helps clarify dosing schedules and may prompt consideration of more affordable compounded alternatives.

How Many Doses Does One Ozempic Pen Contain?

A standard Ozempic pen comes pre-filled with either 1.5 mL or 3 mL of liquid semaglutide. The 1.5 mL pen supplies enough medication for four weekly doses at the 0.25 mg starting dose, while the 3 mL pen holds enough for up to four weeks at higher maintenance doses. The exact number of usable injections depends on the patient's prescribed dose level, which typically increases over 4 to 8 weeks.

Each Ozempic pen has a built-in needle and dial mechanism that allows patients to select their exact weekly dose in 0.25 mg increments. Once a patient reaches their target dose—commonly 0.5 mg, 1 mg, or 2.4 mg—the pen will deliver that same amount each week until it runs out. Patients cannot adjust the total dose within a pen; instead, they must request a new pen when their current one is depleted.

Understanding Ozempic Pen Mechanics and Dosing Schedules

Ozempic pens are programmed to release a fixed amount of semaglutide with each button press, making the injection process straightforward for most patients. The needle retracts automatically after injection, reducing the risk of needle-stick injury and making disposal safer. Patients receive detailed training on how to hold the pen, select their dose dial, and inject subcutaneously into the abdomen, thigh, or upper arm.

Most patients begin Ozempic at 0.25 mg weekly and increase by 0.25 mg increments every four weeks until reaching their therapeutic dose or the maximum tolerated dose of 2.4 mg weekly. This gradual escalation helps reduce gastrointestinal side effects like nausea and constipation. A single Ozempic pen lasts approximately four weeks at any given dose level, after which the patient requires a new prescription and pen.

Cost Comparison: Brand Ozempic vs. Compounded Semaglutide Injections

Brand-name Ozempic costs significantly more than compounded alternatives, often exceeding $900 to $1,200 per month even with insurance, and considerably more without coverage. PlexusDx offers compounded semaglutide injections prepared by licensed 503A compounding pharmacies at a flat rate of $149 per month, regardless of dose level—meaning the price remains the same whether a patient is at 0.25 mg or 2.4 mg weekly.

Compounded semaglutide from PlexusDx provides the same active ingredient and injection route as brand Ozempic, delivered in multi-dose vials that patients can use for several weeks. This approach eliminates the per-pen expense structure and provides transparent, predictable monthly pricing. HSA and FSA funds are eligible for PlexusDx compounded semaglutide, further reducing out-of-pocket cost for eligible patients.

Why Choose PlexusDx Compounded Semaglutide Over Ozempic Pens

PlexusDx compounded semaglutide injections deliver the same pharmaceutical benefits as Ozempic at a fraction of the cost, with no insurance requirement and service available across all 50 states. Patients receive their medication in multi-dose vials with syringes and supplies included, simplifying the ordering and administration process. The flat monthly pricing structure ensures that dose increases do not trigger higher costs, honoring the commitment that 'your dose may need to go up, but your price won't.'

For patients seeking personalized insight into their genetic response to semaglutide therapy, PlexusDx offers the Precision Peptide Genetic Test as an add-on after the first month of treatment. This test analyzes 14 metabolic pathways and 49 peptides, including key variants like GLP1R rs6923761 and GIPR rs1800437, helping patients and providers understand individual predispositions to weight loss response and side effect tolerance. Compounded semaglutide from PlexusDx represents a transparent, evidence-based alternative to brand pens for patients prioritizing accessibility and affordability.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many weeks does one Ozempic pen last?

A standard Ozempic pen contains enough medication for approximately four weeks of weekly injections at a constant dose level. Once depleted, patients must obtain a new pen prescription. With PlexusDx compounded semaglutide, multi-dose vials last several weeks depending on individual dose, eliminating the need for frequent pen replacements.

Can you refill an Ozempic pen or reuse it?

Ozempic pens are single-use, pre-filled devices designed for disposal once empty; they cannot be refilled or reused. This contributes to the ongoing cost of Ozempic therapy, as patients continuously purchase new pens throughout treatment. PlexusDx's multi-dose vial format offers a more economical, sustainable alternative.

What is the starting dose and how does it increase?

Most patients start Ozempic at 0.25 mg weekly and increase by 0.25 mg increments every four weeks, reaching typical maintenance doses of 0.5 mg, 1 mg, or 2.4 mg. Dose escalation is gradual to minimize nausea and other GI effects. PlexusDx compounded semaglutide follows the same evidence-based dosing protocol at a flat monthly price.

Does PlexusDx semaglutide injection cost more if I increase my dose?

No. PlexusDx compounded semaglutide injection is priced at a flat $149 per month regardless of dose level, meaning patients never pay more as their treatment increases. This pricing model removes financial barriers to reaching therapeutic doses.

How does the Precision Peptide Genetic Test help personalize semaglutide therapy?

The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R pathways to identify individual predispositions toward weight loss response and potential side effect profiles. This $99 add-on test, available after the first month of PlexusDx treatment, helps providers fine-tune therapy and set realistic expectations based on genetic factors rather than trial-and-error dosing.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves